Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors

Advances in Experimental Medicine and Biology

Volumn 431, Issue , 1998, Pages 549-553

  Inai, Kunihiro ^a   Tsutani, Hiroshi ^a   Yamauchi, Takahiro ^a   Nakamura, Toru ^a   Ueda, Takanori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATE; INOSINATE DEHYDROGENASE; MIZORIBINE; MYCOPHENOLIC ACID; TIAZOFURIN;

CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL STRAIN HL 60; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031863587     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5381-6_106     Document Type: Conference Paper

References (15)

1. Jackson RC, et al. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 1975;256:331-333.
2. Konno Y, et. al. Expression of human IMP dehydrogenase type I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J Biol Chem 1991;266:506-509.
3. Collart FR, et al. Cloning and sequence analysis of the human and Chinese hamster inosine-5′-monophosphate dehydrogenase cDNAs. J Biol Chem 1988;263:15769-15772.
4. Olah E, et al. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells. Proc Natl Acad Sci USA 1988;85:6533-6537.
5. Lucus DC, et al. Purine metabolism in myeloid precursor cells during maturation. J Clin Invest 1983;72:1889-1900.
6. Sidi Y, et al. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor. Br J Cancer 1988;58:61-63.
7. Nagai M, et al. Proliferation-Iinked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 cells. Cancer Res 1992;52: 258-261.
8. Nagai M, et al. Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res 1991;51:3886-3890.
9. Inai, K, et al. Differentiation induction in non-lymphocytic leukemia cells upon treatment with mizoribine. Int J Hematol 1997 (in press).
10. Yamauchi T, et al. A new sensitive method for determination of intracellular 1-β-D-arabinofuranosylcytosine 5′-triphosphate content in human materials in vivo. Cancer Res 1996;56:1800-1804.
11. Kiguchi K, et al. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: Altered patterns of IMP dehydrogenase expression and activity. Cell Growth Differ 1990; 1:259-270.
12. Kiguchi K, et al. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphocytoid leukemia cells by mycophenolic acid and tiazofurin. Exp Cell Res 1990:187:47-53.
13. Eugui EM, et al. Immunosuppressive activity of mycophenolate mofetil. Ann NY Acad Sci 1993;685:309-329.
14. Sokoloski JA, et al. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5′-phosphate dehydrogenase. Cancer Res 1986;46:2314-2319.
15. Kharbanda SM, et al. Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL-60 cells. Blood 1990:75:583-588.